Stand Up To Cancer, Jazz Pharmaceuticals Collaborate to Accelerate Drug Development

In an interview with Pharmacy Times®, Lee Helman, MD, vice chair on Stand Up To Cancer's Scientific Advisory Committee, discusses the research collaboration between Stand Up To Cancer and Jazz Pharmaceuticals.

Pharmacy Times interviewed Lee Helman, MD, vice chair on Stand Up To Cancer's Scientific Advisory Committee, on the collaboration between Jazz Pharmaceuticals and Stand Up To Cancer, intended to accelerate treatment development.

In this discussion, Helman provides an overview of the collaboration goals, as well as which projects are supported by this effort, including the investigation of the use of lurbinectedin for rare, difficult-to-treat pediatric solid tumors.